ScopusElsevier Scopus
Status
Active
Coverage
2020–present
Source type
Journal
Open access
Yes
CiteScore
3.3
SJR · SCImago
0.503
Q3 SJR quartile
H-index
11
Best quartile
Q2 · 51st pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 87 / 179 | 51st | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Rare Disease
Therapeutic Advances in Rare Disease is Scopus-indexed (Q2, CiteScore 3.3), WoS ESCI, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2633-0040Verify ISSN ↗
Publisher: SAGE Publications Ltd
Scopus · Q2WoS · ESCIOpen Access
3.3
CiteScore 2025
Q2
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Therapeutic Advances in Rare Disease indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q2, CiteScore 3.3.
What quartile is Therapeutic Advances in Rare Disease in Scopus?
Therapeutic Advances in Rare Disease is Q2 in Internal Medicine (rank 87 of 179), by CiteScore 2025.
What is the impact factor of Therapeutic Advances in Rare Disease?
Therapeutic Advances in Rare Disease is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.503, quartile Q3, with an H-index of 11.
How much does it cost to publish in Therapeutic Advances in Rare Disease?
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Who publishes Therapeutic Advances in Rare Disease and what is its ISSN?
Therapeutic Advances in Rare Disease is published by SAGE Publications Ltd. Its ISSN is 2633-0040.
Is Therapeutic Advances in Rare Disease in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Therapeutic Advances in Rare Disease open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Therapeutic Advances in Rare Disease? — open metrics via OpenAlex
Therapeutic Advances in Rare Disease has an h-index of 14 and a 2-year mean of 1.94 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q2. On 2-year citations it ranks #73 of 172 Scopus journals in Internal Medicine.
14
h-index
1.94
2-yr mean citations
20
i10-index
143
works indexed
721
total citations
Publication fee · open access list price, US$
No fee
2-yr mean citations, among Scopus journals in the same subject
#73 of 172 Top 43% Internal Medicine
Therapeutic Advances in Rare Disease published 24 papers in 2025; its busiest recent year was 2024 with 43. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Therapeutic Advances in Rare Disease? — latest 88 articles, 2023–2026
In its latest 88 research articles (2023–2026), authors are most often from United States (51.9%), Canada (7.4%) and United Kingdom (7.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Therapeutic Advances in Rare Disease? — indicators, not proof of misconduct
Scopus status: Active. 3 retracted papers are recorded (21 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 3 · 21 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration51.9% of recent authorship from United States
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
THERAPEUTIC ADVANCES IN REPRODUCTIVE HEALTH WoS ESCI DOAJ Therapeutic Advances in Respiratory Disease Scopus Q2 WoS SCIE DOAJ Therapeutic Advances in Vaccines and Immunotherapy Scopus Q1 DOAJ Therapeutic Hypothermia and Temperature Management Scopus Q2 WoS SCIE Thesis Eleven Scopus Q1 WoS ESCI Thyroid Scopus Q1 WoS SCIE Tissue Engineering - Part A Scopus Q2 WoS SCIE Tissue Engineering - Part B: Reviews Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.